{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:36:30Z","timestamp":1787769390275,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.euroneuro.2020.01.011","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T16:36:45Z","timestamp":1581179805000},"page":"139-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"33","author":[{"given":"Arthur","family":"Caye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7328-6204","authenticated-orcid":false,"given":"Luisa K.","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paz","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7691-4149","authenticated-orcid":false,"given":"Christian","family":"Kieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2020.01.011_bib0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-0327(96)00010-9","article-title":"TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression","volume":"38","author":"Amsterdam","year":"1996","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-8993(94)91424-9","article-title":"Subchronic administration of fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain","volume":"635","author":"Baumgartner","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0004","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0006-3223(94)90092-2","article-title":"A comparison of the effects of imipramine and fluvoxamine on the thyroid axis","volume":"36","author":"Brady","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJMra1901214","article-title":"Drug effects on the thyroid","volume":"381","author":"Burch","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0006","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.64.6.679","article-title":"Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Cooper-Kazaz","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0007","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/thy.2008.0261","article-title":"Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function","volume":"19","author":"de Carvalho","year":"2009","journal-title":"Thyroid: Off. J. Am. Thyroid Assoc."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0008","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5455\/apd.214058","article-title":"Metabolic parameters in patients with major depression treated with escitalopram","volume":"17","author":"Demirci","year":"2016","journal-title":"Anadolu Psikiyatri Dergisi-Anatolian J. Psychiatry"},{"issue":"12","key":"10.1016\/j.euroneuro.2020.01.011_bib0009","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2019.2859","article-title":"Association of antidepressant use with adverse health outcomes: a systematic umbrella review","volume":"76","author":"Dragioti","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.pnpbp.2007.12.029","article-title":"Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder","volume":"32","author":"Eker","year":"2008","journal-title":"Progr. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0011","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1530\/EJE-14-0285","article-title":"Beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis","volume":"171","author":"Fliers","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.euroneuro.2020.01.011_bib0012","first-page":"1","article-title":"Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching","volume":"6","author":"Fuentes","year":"2018","journal-title":"Train. Pract. Pharm. (Basel)"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0013","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0269881103174001","article-title":"Thyroid indices and response to fluoxetine and nortriptyline in major depression","volume":"17","author":"Gendall","year":"2003","journal-title":"J. Psychopharmacol. (Oxford, Engl.)"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1139\/jpn.0437","article-title":"Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors","volume":"29","author":"Gitlin","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0015","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.1981.03310440019016","article-title":"Hypothyroidism and depression. Evidence from complete thyroid function evaluation","volume":"245","author":"Gold","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0016","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0017","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/thy.1998.8.951","article-title":"The thyroid axis and depression","volume":"8","author":"Jackson","year":"1998","journal-title":"Thyroid: Off. J. Am. Thyroid Assoc."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0018","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archpsyc.1993.01820170065008","article-title":"A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression","volume":"50","author":"Joffe","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0019","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatry. Revue Canadienne de Psychiatrie"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000026683","article-title":"Effect of paroxetine on thyroid hormone levels in severely depressed patients","volume":"42","author":"Konig","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0021","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/JOE-10-0481","article-title":"Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease","volume":"209","author":"Maia","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0022","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199710023371415","article-title":"Elevated serum thyrotropin in thyroxine treated patients with hypothyroidism given sertraline [4](multiple letters)","volume":"337","author":"McCowen","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0023","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1210\/er.2014-1081","article-title":"Genetic determination of the hypothalamic-pituitary-thyroid axis: Where do we stand?","volume":"36","author":"Medici","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0024","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jama.2017.8036","article-title":"Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D Randomized Clinical Trial","volume":"318","author":"Mohamed","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0025","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0278-5846(99)00087-1","article-title":"Red blood cell triiodothyronine uptake in unipolar major depression: effect of a chronic antidepressant treatment","volume":"24","author":"Moreau","year":"2000","journal-title":"Progr. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0027","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1176\/ajp.2006.163.9.1519","article-title":"A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report","volume":"163","author":"Nierenberg","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0028","unstructured":"OECD, 2017. Chapter 10. Pharmaceutic Figure 10.9 Antidepressant Drugs Consumption, 2000 and 2015 (or nearest year). Health at a Glance 2017: OECD Indicators."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0029","first-page":"143","article-title":"The effect of escitalopram on thyroid function in patients with depression: An experience from Government Medical College Srinagar and Associated Hospitals","volume":"6","author":"Rather","year":"2017","journal-title":"Int. J. Med. Res. Health Sci."},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000054954","article-title":"Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients","volume":"45","author":"\u0160agud","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0031","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0006-3223(93)90311-Z","article-title":"The effects of antidepressants on the thyroid axis in depression","volume":"33","author":"Shelton","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0032","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.01.011_bib0033","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res. Synth. Methods"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20300341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:55:50Z","timestamp":1760378150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20300341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"alternative-id":["S0924977X20300341"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.01.011","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}